CAS: 866823-63-4; 7,8,9,10-Tetrahydro-6H-6,10-Methanoazepino[4,5-G]Quinoxaline Dihydrochloride

该化合物是α4β2 尼基乙酰胆碱受体的选择性局部刺激剂, 主要是通过减少尼古丁的渴望和抽取症状, 减少尼古丁的有益效果来表示戒烟. 化合物的机制涉及到对亲于尼古丁的受体点的约束, 从而调节麦氏菌系统中的多甲基胺活性. 临床研究表明, 相对于安慰剂或其他药理疗法, 其提高长期禁欲率的效果是有效的. 甲状腺二氯化物以平板形式口头施用, 其剂量乳液乳液可优化耐性. 其精密的药性皮肤特征和有针对性的行动使得它成为经临床验证的戒烟疗法的选择.

结构式图片

合成工艺路线路线简述

  • 230615-59-5 = 866823-63-4
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Dihydroxide Solvents: Methanol; 2.5 H,45 Psi,Rt2.1 Solvents: Tetrahydrofuran,Water; 2.5 H,55 °C3.1 Reagents: Sodium Carbonate Solvents: Methanol,Water; 2 H,70 °C4.1 Reagents: Hydrochloric Acid Solvents: Methanol,Ethyl Acetate; Rt
    标题:Varenicline: An α4β2 Nicotinic Receptor Partial Agonist For Smoking Cessation
    作者:Coe,Jotham W.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:2005 卷标:48(10) 页码:3474-3477]

    249296-44-4 = 866823-63-4
    反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Methanol,Ethyl Acetate; Rt
    标题:Varenicline: An α4β2 Nicotinic Receptor Partial Agonist For Smoking Cessation
    作者:Coe,Jotham W.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:2005 卷标:48(10) 页码:3474-3477]

    230615-70-0 = 866823-63-4
    反应条件:1.1 Reagents: Sodium Carbonate Solvents: Methanol,Water; 2 H,70 °C2.1 Reagents: Hydrochloric Acid Solvents: Methanol,Ethyl Acetate; Rt
    标题:Varenicline: An α4β2 Nicotinic Receptor Partial Agonist For Smoking Cessation
    作者:Coe,Jotham W.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:2005 卷标:48(10) 页码:3474-3477]

    230615-69-7 + 517-21-5 = 866823-63-4
    反应条件:1.1 Solvents: Tetrahydrofuran,Water; 2.5 H,55 °C2.1 Reagents: Sodium Carbonate Solvents: Methanol,Water; 2 H,70 °C3.1 Reagents: Hydrochloric Acid Solvents: Methanol,Ethyl Acetate; Rt
    标题:Varenicline: An α4β2 Nicotinic Receptor Partial Agonist For Smoking Cessation
    作者:Coe,Jotham W.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:2005 卷标:48(10) 页码:3474-3477]

    230615-51-7 = 866823-63-4
    反应条件:1.1 Reagents: Trifluoromethanesulfonic Acid,Nitric Acid Solvents: Dichloromethane,Water; 10 Min,0 °C; 0 °C -> -78 °C1.2 Solvents: Dichloromethane; 5 Min,-78 °C; 30 Min,-78 °C; 1 H,-78 °C -> 0 °C2.1 Reagents: Hydrogen Catalysts: Palladium Dihydroxide Solvents: Methanol; 2.5 H,45 Psi,Rt3.1 Solvents: Tetrahydrofuran,Water; 2.5 H,55 °C4.1 Reagents: Sodium Carbonate Solvents: Methanol,Water; 2 H,70 °C5.1 Reagents: Hydrochloric Acid Solvents: Methanol,Ethyl Acetate; Rt
    标题:Varenicline: An α4β2 Nicotinic Receptor Partial Agonist For Smoking Cessation
    作者:Coe,Jotham W.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:2005 卷标:48(10) 页码:3474-3477]

    230615-52-8 = 866823-63-4
    反应条件:1.1 Reagents: Pyridine Solvents: Dichloromethane; 10 Min,0 °C; 3 H,0 °C2.1 Reagents: Trifluoromethanesulfonic Acid,Nitric Acid Solvents: Dichloromethane,Water; 10 Min,0 °C; 0 °C -> -78 °C2.2 Solvents: Dichloromethane; 5 Min,-78 °C; 30 Min,-78 °C; 1 H,-78 °C -> 0 °C3.1 Reagents: Hydrogen Catalysts: Palladium Dihydroxide Solvents: Methanol; 2.5 H,45 Psi,Rt4.1 Solvents: Tetrahydrofuran,Water; 2.5 H,55 °C5.1 Reagents: Sodium Carbonate Solvents: Methanol,Water; 2 H,70 °C6.1 Reagents: Hydrochloric Acid Solvents: Methanol,Ethyl Acetate; Rt
    标题:Varenicline: An α4β2 Nicotinic Receptor Partial Agonist For Smoking Cessation
    作者:Coe,Jotham W.; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:2005 卷标:48(10) 页码:3474-3477

海关参考信息

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016 Jun 18;387(10037):2507-20. doi: 10.1016/S0140-6736(16)30272-0. Epub 2016 Apr 22. 333(21):1876-1886. doi: 10.1001/jama.2025.3810.
3: Cinciripini PM, Green CE, Shete S, Minnix JA, Robinson JD, Cui Y, Kim S, Kypriotakis G, Beneventi D, Blalock JA, Versace F, Karam-Hage M. Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial. JAMA. 2024 May 28;331(20):1722-1731. doi: 10.1001/jama.2024.4183.
4: Correia C, Fernandes S, Correia T, Soares-de-Almeida L, Filipe P. Varenicline-induced drug eruption: case and review of the literature. Dermatol Online J. 2023 Feb 15;29(1). doi: 10.5070/D329160217. 2025 Jan–. 82(14):1481-1488. doi: 10.1007/s40265-022-01782-4. Epub 2022 Oct 5.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知